{
    "code": "02022177",
    "time": "2015-06-25 17:08:23",
    "許可證字號": "衛署藥輸字第022177號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "有效日期": "107\/05\/14",
    "發證日期": "87\/05\/14",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA00202217702",
    "中文品名": "克立生注射劑",
    "英文品名": "CLEXANE INJECTION",
    "適應症": "預防手術後靜脈血栓症。",
    "劑型": "270注射劑",
    "包裝": "注射針筒 盒裝",
    "藥品類別": "05限由醫師使用",
    "管制藥品分類級別": "",
    "主成分略述": "ENOXAPARIN SODIUM",
    "限制項目": [
        "02輸入"
    ],
    "申請商名稱": "1424601100  賽諾菲股份有限公司",
    "申請商地址": "台北市松山區復興北路337號12、13、14樓",
    "主製造廠": {
        "製造廠名稱": "F150086100  Sanofi Winthrop industrie",
        "製造廠廠址": "180 RUE JEAN-JAURES B.P. 40 94702 MAISONS ALFORT CEDEX FRANCE15,RUE DE LA VANNNE,92120-MONTROUGE,FRANCE",
        "製造廠公司地址": "15,RUE DE LA VANNNE,92120-MONTROUGE,FRANCE",
        "製造廠國別": "FRANCE",
        "製程": ""
    },
    "CCC號列": "30019010002 肝素及其鹽類Heparin and its salts",
    "藥理治療分類": "",
    "次製造廠": [
        {
            "製造廠名稱": "F150211100  SANOFI-AVENTIS FRANCE",
            "製造廠廠址": "1-13, BOULEVARD ROMAIN ROLLAND 75014 PARIS, FRANCE",
            "製造廠公司地址": "",
            "製造廠國別": "FRANCE",
            "製程": "許可證持有者"
        }
    ],
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "2012401610",
            "成分名稱": "ENOXAPARIN SODIUM",
            "含量描述": "",
            "含量": "2000.0000000000",
            "單位": "ANTI-XA IU"
        },
        {
            "成分類別": "主成分",
            "成分代碼": "2012401610",
            "成分名稱": "ENOXAPARIN SODIUM",
            "含量描述": "",
            "含量": "4000.0000000000",
            "單位": "ANTI-XA IU"
        }
    ],
    "仿單外盒": [
        {
            "title": "仿單 Clexane 0.2ml-leaflet-E-CCDS v12-approved-103-10-20.pdf Clexane 0.2ml-leaflet-C-CCDS v12-approved-103-10-20.pdf Clexane 0.2ml-leaflet-E-CCDS v11-approved-2014-02-14.pdf Clexane 0.2ml-leaflet-C-CCDS v11approved-2014-02-14.pdf Clexane 0.2ml-leaflet-E-CCDS v10-approved-102-08-26.pdf Clexane 0.2ml-leaflet-C-CCDS v10-approved-102-08-26.pdf 020221770026___20110719.jpg 020221770025___20110719.jpg 020221770024___20110719.jpg 020221770023___20110719.jpg 020221770022___20110719.jpg 020221770021___20110719.jpg 020221770020___20110719.jpg 020221770019___20110719.jpg 020221770018___20110719.jpg 020221770017___20110719.jpg 020221770016___20110719.jpg 020221770015___20110719.jpg 020221770014___20110719.jpg 020221770013___20110719.jpg 020221770012___20110719.jpg 020221770011___20110719.jpg 020221770010___20110719.jpg 020221770009___20110719.jpg 020221770008___20110719.jpg 020221770007___20110719.jpg 020221770006___20110719.jpg 020221770005___20110719.jpg 020221770004___20110719.jpg 020221770004___20100729.pdf 020221770003___20110719.jpg 020221770003___20100729.pdf 020221770002___20110719.jpg 020221770002___20110705.jpg 020221770002.jpg 020221770001___20110719.jpg 020221770001___20110705.jpg 020221770001.jpg",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02022177&Seq=038&Type=9"
        },
        {
            "title": "外盒 020221770008.jpg 020221770007.jpg 020221770006.jpg 020221770005.jpg 020221770004.jpg 020221770003.jpg 020221770002.jpg 020221770001.jpg",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02022177&Seq=008&Type=8"
        }
    ]
}